L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum

Optimal excitation and emission wavelengths to analyze amino acids and optimize neurotransmitters quantification using precolumn OPA-derivatization by HPLC

(2015) J. Perucho et al.   AMINO ACIDS

Activation of DREAM (Downstream Regulatory Element Antagonistic Modulator), a Calcium-Binding Protein, Reduces L-DOPA-Induced Dyskinesias in Mice

(2015) Irene Ruiz-DeDiego et al.   BIOLOGICAL PSYCHIATRY

Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling

(2015) Oscar Solís et al.   CEREBRAL CORTEX

Dopaminergic regulation of olfactory type G-protein α subunit expression in the striatum

(2015) I. Ruiz-DeDiego et al.   MOVEMENT DISORDERS

Enhanced histamine H2 excitation of striatal cholinergic interneurons in l-DOPA-induced dyskinesia

(2015) Sean Austin O. Lim et al.   NEUROBIOLOGY OF DISEASE

Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3−/− aphakia mice

(2015) Oscar Solís et al.   NEUROBIOLOGY OF DISEASE

Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia

(2014) Michel Engeln et al.   CEREBRAL CORTEX

Correlations between plasma levels of amino acids and nonmotor symptoms in Parkinson’s disease

(2014) Qing Tong et al.   JOURNAL OF NEURAL TRANSMISSION

Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics

(2014) Peter A. LeWitt   MOVEMENT DISORDERS

Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia

(2014) Tim Fieblinger et al.   Nature Communications

L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2–Expressing Projection Neurons in Dyskinetic Mice

(2013) Luz M. Suárez et al.   BIOLOGICAL PSYCHIATRY

Change in Plasma Levels of Amino Acid Neurotransmitters and its Correlation with Clinical Heterogeneity in Early Parkinson's Disease Patients

(2013) Yong-Sheng Yuan et al.   CNS Neuroscience & Therapeutics

Parkinson disease: from pathology to molecular disease mechanisms

(2013) David T. Dexter et al.   FREE RADICAL BIOLOGY AND MEDICINE

Tyrosine-free amino acid mixtures reduce physiologically-evoked release of dopamine in a selective and activity-dependent manner

(2013) Marisa Le Masurier et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease

(2013) Ramiro González-Aparicio et al.   NEUROBIOLOGY OF DISEASE

Counteraction by Nitric Oxide Synthase Inhibitor of Neurochemical Alterations of Dopaminergic System in 6-OHDA-Lesioned Rats Under l-DOPA Treatment

(2013) Elaine Del-Bel et al.   NEUROTOXICITY RESEARCH

Methamphetamine and Parkinson's Disease

(2013) Noelia Granado et al.   Parkinsons Disease

L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: Insights into regulation and function

(2012) Isabel Espadas et al.   NEUROBIOLOGY OF DISEASE

Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: Motor impairments identify extent of dopamine depletion at three different lesion sites

(2011) Andreas Heuer et al.   BEHAVIOURAL BRAIN RESEARCH

Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: Predicting l-DOPA-induced dyskinesia

(2011) Gaynor A. Smith et al.   BEHAVIOURAL BRAIN RESEARCH

Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate l-DOPA-induced dyskinesia

(2011) Francesco Errico et al.   EXPERIMENTAL NEUROLOGY

Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels

(2011) Simone Bido et al.   JOURNAL OF NEUROCHEMISTRY

In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels

(2011) Flora Mela et al.   NEUROBIOLOGY OF DISEASE

Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation

(2011) Mario Gustavo Murer et al.   Frontiers in Neuroanatomy

Relationships between large neutral amino acid levels in plasma, cerebrospinal fluid, brain microdialysate and brain tissue in the rat

(2010) Rodolfo Bongiovanni et al.   BRAIN RESEARCH

l-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata

(2010) Claudia Rangel-Barajas et al.   NEUROBIOLOGY OF DISEASE

Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA–Induced Dyskinesia and Histone Activation

(2009) Sanja Darmopil et al.   BIOLOGICAL PSYCHIATRY

The rotational model and microdialysis: Significance for dopamine signalling, clinical studies, and beyond

(2009) Mario Herrera-Marschitz et al.   PROGRESS IN NEUROBIOLOGY

Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by l-DOPA

(2008) Sanja Darmopil et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

D-Aspartate Prevents Corticostriatal Long-Term Depression and Attenuates Schizophrenia-Like Symptoms Induced by Amphetamine and MK-801

(2008) F. Errico et al.   JOURNAL OF NEUROSCIENCE